Due Diligence service

Market Prioritization and Sequencing, Go-to-Market Strategy and Technology Launch Readiness

Provided by IGES Italy Pharma Consulting · Italy

Service description

This individualised service supports technologies and teams that need early visibility on market access, HTA, and reimbursement requirements across European countries. The service typically runs over 4–6 weeks and helps innovators understand how future HTA and reimbursement outcomes may affect development priorities, pricing assumptions, and commercial potential. Activities include cross-country assessment of HTA and reimbursement scenarios, review of payer and evidence expectations, identification of access-related evidence gaps, development of price and reimbursement assumptions, and expert input from selected local market access and HTA advisors. Where relevant, the service also supports optimisation of the evidence-generation strategy by integrating likely HTA requirements into development planning. The goal is to reduce downstream reimbursement risk and improve the alignment between product development and future access requirements. Expected outcomes include an early HTA and reimbursement risk map, country-level access assumptions, recommendations to strengthen reimbursement preparedness and price scenarios.

This individualised service supports EIC Transition and EIC Accelerator beneficiaries that are preparing for first commercialisation or expansion into new European markets and definition of a structured and access-oriented market entry pathway. Activities include assessment of launch sequence and country prioritisation, review of pricing and reimbursement pathways, capability gap assessment, stakeholder mapping, identification of evidence gaps relevant for launch, and refinement of the product value story for decision-makers. The goal is to help beneficiaries align commercial, access, and evidence considerations and to define the optimal order and conditions for entry into selected European markets. Expected outcomes include a launch sequence recommendation, a country-level market entry roadmap, a prioritised HTA and reimbursement preparation plan, and a concise set of actions to reduce pre-launch access risk. The service is delivered remotely through tailored expert sessions.

Deadlines are decided on each project bases and request. No specific disclaimers. Projects are built based on the technology and customer need.

← Back to Due Diligence services